VEGFC and colitis: In line with this, increased levels of IL-10 in combination with a reduction of IL-9, which is associated with intestinal barrier disruption, have been reported upon treatment with adenovirally delivered VEGF-C in mice undergoing DSS-induced colitis (52, 53).